| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING | 
|---|---|---|---|---|---|---|
GSK J1 | 1373422-53-7 | sc-391113 sc-391113A  | 10 mg 50 mg  | $189.00 $797.00  | ||
GSK J1 acts as a selective inhibitor of JMJD3, showcasing a unique mechanism of action through its ability to stabilize the enzyme's inactive conformation. This compound engages in specific hydrogen bonding and electrostatic interactions, which modulate the enzyme's catalytic activity. Its kinetic profile reveals a slow dissociation rate, promoting sustained inhibition. Additionally, GSK J1's lipophilic characteristics enhance its membrane permeability, facilitating cellular uptake and interaction with target pathways.  | ||||||
GSK J4 | sc-391114 sc-391114A  | 10 mg 50 mg  | $215.00 $860.00  | 5 | ||
GSK J4 serves as a potent inhibitor of JMJD3, characterized by its ability to disrupt the enzyme's active site through unique steric hindrance. This compound exhibits a distinctive binding affinity, leading to altered reaction kinetics that favor prolonged enzyme inhibition. Its hydrophobic interactions contribute to a favorable conformational change, enhancing selectivity. GSK J4's structural features allow for specific molecular recognition, influencing downstream signaling pathways effectively.  | ||||||
5-Carboxy-8-hydroxyquinoline | 5852-78-8 | sc-397023 | 5 mg | $86.00 | ||
5-Carboxy-8-hydroxyquinoline acts as a selective inhibitor of JMJD3, showcasing unique chelation properties that facilitate strong interactions with metal ions in the enzyme's active site. This compound's ability to form stable complexes alters the enzyme's conformation, impacting its catalytic efficiency. Additionally, its polar functional groups enhance solubility, promoting effective diffusion in biological systems and influencing substrate accessibility.  | ||||||
JIB 04 | 199596-05-9 | sc-397040 | 20 mg | $177.00 | ||
JIB 04 is a cell permeable and selective Jumonji histone demethylase inhibitor  | ||||||
2,4-Pyridinedicarboxylic acid monohydrate | 207671-42-9 | sc-225693 | 1 g | $28.00 | ||
It can act as a competitive inhibitor to the 2-oxoglutarate co-factor, potentially reducing JMJD3 activity.  | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A  | 100 mg 500 mg  | $130.00 $270.00  | 37 | |
Suberoylanilide Hydroxamic Acid can chelate the iron in the JMJD3 active site, potentially inhibiting its histone demethylase activity.  | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A  | 50 g 100 g  | $52.00 $87.00  | 7 | |
Disulfiram can inhibit JMJD3 by chelating the active site metal ions required for its enzymatic activity.  | ||||||
5′-Deoxy-5′-methylthioadenosine | 2457-80-9 | sc-202427 | 50 mg | $120.00 | 1 | |
As a byproduct of polyamine synthesis, it can indirectly inhibit JMJD3 activity through feedback mechanisms on SAM-dependent methylases.  | ||||||
Dimethyloxaloylglycine (DMOG) | 89464-63-1 | sc-200755 sc-200755A sc-200755B sc-200755C  | 10 mg 50 mg 100 mg 500 mg  | $82.00 $295.00 $367.00 $764.00  | 25 | |
DMOG is a cell-permeable inhibitor of 2-oxoglutarate-dependent dioxygenases, which could indirectly inhibit JMJD3 activity.  | ||||||